机构：[1]The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, Hu'nan, China [2] Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hu'nan, China [3]Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China [4] Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
This study was financially supported by the National Natural
Science Foundation of China (Nos. 81202535 and 81470493), the
Natural Science Fund Project of the Hunan Provincial Science and
Technology Department (2018JJ6097), the Technology Research and
Development Center of Chenzhou, the Science and Technology Bureau
of Chenzhou, Hunan Province (zdyf201821), and the Science and
Technology Strategic Cooperation Project of Luzhou Municipal People's
Government and Southwest Medical University, Sichuan Province,
China (2016LZXNYD-J14).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|3 区医学
小类|3 区外周血管病
最新[2023]版：
大类|4 区医学
小类|4 区外周血管病
第一作者：
第一作者机构：[2] Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hu'nan, China
共同第一作者：
通讯作者：
通讯机构：[1]The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, Hu'nan, China [2] Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hu'nan, China [*1]The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, Hu'nan 423000, China.
推荐引用方式(GB/T 7714)：
Chen Gen,Chen Xiao-Lan,Xu Cang-Bao,et al.Toll-like receptor protein 4 monoclonal antibody inhibits mmLDL-induced endothelium-dependent vasodilation dysfunction of mouse mesenteric arteries.[J].Microvascular research.2020,127:103923.doi:10.1016/j.mvr.2019.103923.
